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Abstract
Background: BCG is the most widely used vaccine of all time and remains the only licensed vaccine for use
against tuberculosis in humans. BCG also protects other species such as cattle against tuberculosis, but due to its
incompatibility with current tuberculin testing regimens remains unlicensed. BCG’s efficacy relates to its ability to
persist in the host for weeks, months or even years after vaccination. It is unclear to what degree this ability to
resist the host’s immune system is maintained by a dynamic interaction between the vaccine strain and its host as
is the case for pathogenic mycobacteria.
Results: To investigate this question, we constructed transposon mutant libraries in both BCG Pasteur and BCG
Danish strains and inoculated them into bovine lymph nodes. Cattle are well suited to such an assay, as they are
naturally susceptible to tuberculosis and are one of the few animal species for which a BCG vaccination program
has been proposed. After three weeks, the BCG were recovered and the input and output libraries compared to
identify mutants with in vivo fitness defects. Less than 10% of the mutated genes were identified as affecting in
vivo fitness, they included genes encoding known mycobacterial virulence functions such as mycobactin synthesis,
sugar transport, reductive sulphate assimilation, PDIM synthesis and cholesterol metabolism. Many other
attenuating genes had not previously been recognised as having a virulence phenotype. To test these genes, we
generated and characterised three knockout mutants that were predicted by transposon mutagenesis to be
attenuating in vivo: pyruvate carboxylase, a hypothetical protein (BCG_1063), and a putative cyclopropane-fatty-
acyl-phospholipid synthase. The knockout strains survived as well as wild type during in vitro culture and in bovine
macrophages, yet demonstrated marked attenuation during passage in bovine lymph nodes confirming that they
were indeed involved in persistence of BCG in the host.
Conclusion: These data show that BCG is far from passive during its interaction with the host, rather it continues to
employ its remaining virulence factors, to interact with the host’s innate immune system to allow it to persist, a
property that is important for its protective efficacy.
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Background
Mycobacterium bovis BCG is the only vaccine, with
proven efficacy against all three major mycobacterial
pathogens, M. tuberculosis [1], M. bovis [2, 3] and M.
leprae [4]. It is also the most widely administered vac-
cine of all time [5] with 90% of world’s children receiving
BCG and over 120 million doses used each year. How-
ever, humans are not the only recipients. BCG vaccin-
ation has also been used to protect a variety of both wild
and domestic species against M. bovis, including cattle
and goats [6–9]. However, its widespread use in animals
and in particular cattle, is compromised by the inability
of the current tuberculin-based skin test regimens to
distinguish M. bovis infection from BCG vaccination [9].
BCG was derived in the early 1900s by Calmette and
Guérin, who sequentially subcultured an M. bovis isolate
230 times, until it lost the ability to cause disease in
guinea pigs [8]. Although Calmette and Guérin’s BCG
was attenuated, it still retained the ability to disseminate
and survive in many infection models including guinea
pigs, deer [7, 10] and cows (Vordermeier et al. Unpub-
lished data). In humans, BCG can be recovered in skin bi-
opsies weeks after inoculation [11] and has, on occasions,
been re-isolated from individuals many years after vaccin-
ation [12, 13]. In immuno-compromised mice and
humans, BCG retains sufficient residual virulence to cause
disseminated disease [14, 15]. This is particularly apparent
in HIV positive children [16, 17]. Studies in 2007 pre-
dicted that continued use of BCG in HIV-infected chil-
dren would result in approximately 400 cases of
disseminated BCG infection per 100,000 vaccination [18];
a finding that led to the World Health Organization
(WHO) ceasing to recommend BCG vaccination for in-
fants who show evidence of HIV infection [19]. A correl-
ation between this residual virulence and BCG’s efficacy
was proposed as long ago as 1952 [20] and has been con-
firmed in mice [21] where the ability to persist is associ-
ated with a prolonged protective immune response
characterised by the presence of CD4 TEM cells and an
IFN-γ response [22]. Exactly how BCG is able to persist
after vaccination is not clear. Is there a dynamic interplay
with the host, in which its remaining virulence factors are
used to resist innate killing mechanisms and to subvert
the immune response in a manner similar to those ob-
served with pathogenic mycobacteria, or are the bacilli
more passive, remaining largely dormant in the host?
Genomic studies have revealed that the serial
sub-culturing of BCG’s progenitor resulted in its loss of
virulence and that later produced the distinct BCG
strains used around the world, was associated with the
sequential loss of several large segments of DNA and the
acquisition of many SNPs, duplications and deletions,
some of which have been shown to contribute to its
attenuation [23, 24]. Yet BCG did not lose all of its
virulence factors, and still retains functions such as chol-
esterol catabolism, resistance to oxidative and nitrosative
stress, various lipid components (mycolic acids, phthio-
cerol dimycocerosate (PDIM), phenolic glycolipid (PGL),
etc.) and others, that in M. bovis and the related M.
tuberculosis are known to increase in vivo fitness [25].
Some of these may still contribute to the persistence of
the vaccine in hosts such as cattle, and promote the
induction of a protective immune response and vaccine
efficacy. However, these same functions could also be in-
volved in reactogenicity and the ability of BCG to cause
disseminated disease in immunocompromised hosts. In-
deed BCG strains derived from ‘later’ serial subcultures
that have lost more of these virulence related functions
than ‘early’ strains [26], are known to have a lower levels
of reactogenicity [27] and to induce lower levels of the
immune responses that correlate with protection [28].
Whether these differences between strains are sufficient
to significantly alter the effectiveness of different BCG
strains in either humans or animals remains difficult to
determine [29, 30].
Transposon mutagenesis is a powerful tool to screen
whole genomes for genes that confer a selectable trait,
in this case virulence. However despite the utility of such
an approach, relatively few genome-scale mycobacterial
transposon libraries have been assessed in animal
models [31, 32] and none in species that are naturally
susceptible to tuberculosis. This is, in part, because of
the difficulty of recovering sufficient mutants from a
relevant animal model to make a genome scale assess-
ment of fitness possible. A genome-wide transposon
mutagenesis study was carried out by Sassetti et al [31]
using an intravenous mouse model of M. tuberculosis
infection and identified 194 virulence-associated genes,
including the mce1 and mce4 operons and genes
involved in biotin synthesis, lipid metabolism and trehal-
ose recycling. Other studies using mice, guinea pigs or
macaques [32–34] have used smaller pools of selected
mutants and have identified virulence associated genes
but not on a genome scale.
As part of a project to develop a diagnostic-compatible
BCG vaccine, we initiated a transposon mutagenesis
study to identify genes required for persistence of BCG
in the bovine host. We utilized a recently developed
model that allows the installation and recovery of large
numbers of BCG following its injection into the prescap-
ular lymph nodes of calves [35], enabling the recovery of
a representative transposon library. Cattle are a particu-
lar relevant model, as they are naturally susceptible to
tuberculosis and are one of the few species, other than
humans, for which a BCG vaccination program has been
proposed.
As BCG strains differ genetically and are known to in-
duce different levels of immune responses we investigated
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two strains, BCG Pasteur 1173P2 and BCG Danish 1331.
Both are ‘later’ strains, but from different BCG lineages
[26]. BCG Pasteur 1173P2, is the strain recommended by
WHO for animal efficacy studies [36] and has demon-
strated efficacy in several animal trials, while BCG Danish
1331 is the only strain licensed in the UK for humans, and
is considered to be the most likely strain to be used if a
vaccination programme for cattle or wildlife were to be
undertaken. Wedlock et al [37] compared the use of both
strains in cattle and demonstrated no difference in
protective efficacy, but did observe higher levels of IFNγ
release from PPD (purified protein derivative) stimulated
whole blood and larger skin test responses with BCG
Pasteur.
By identifying the genetic components of BCG that are
important for in vivo fitness we aim to identify the
residual virulence factors that still operate in BCG and
so describe the mechanisms by which BCG persists long
enough to generate protective immunity.
Results
Construction of the BCG transposon library
The BCG Danish and BCG Pasteur libraries constructed
by transduction with MycoMarT7 contained 1.36 ×
105 cfu and 1.37 × 105 cfu respectively. Sequencing of the
transposon junctions and plots of accumulation curves
predicted that these BCG Danish and Pasteur input li-
braries contained 4.7 × 104 and 2.6 × 104 unique trans-
poson insertion (Additional file 1: Figure S1a and b)
giving genomic coverage of 63 and 34% of all TA sites
respectively. For BCG Danish this is likely to be a near
saturated library as in M. tuberculosis 9% of possible in-
sertion sites have non-permissive motifs and approxi-
mately 15% of possible insertion sites are in essential
genes [38]. In both libraries, sites with non-permissive
motifs had significantly lower rates of transposon
insertion than other TA loci (6.1/5.6% of non-permissive
sites had inserts while 60/34% of permissive site had
inserts in BCG Danish/Pasteur, p < 0.0001).
In vitro gene essentiality and fitness in BCG Pasteur and
BCG Danish input libraries
In order to validate the libraries and to place the results
from the animal passaged output libraries in context, we
predicted the essentiality and relative fitness of genes in
the in vitro input libraries using TRANSIT’s [49] Hidden
Markov Model (HMM) and Resampling methods.
The HMM analysis is designed to identify genes that
are predicted to be essential. When applied to the BCG
Danish and Pasteur input libraries, the analysis predicted
651 and 643 genes to be essential respectively
(Additional file 2: Data S1), with 440 in common
between the two strains. Although this value appears
low, many genes predicted to be essential in only one
strain, were predicted to be growth-deficient in the other,
consistent with them being severely growth-retarding. Of
these essential genes, 77 and 61%, had previously been
identified as essential in M. tuberculosis (based upon a
fully saturated transposon library grown on 7H10 [38]),
further validating the library construction.
We used the TRANSIT’s Resampling method
(Additional file 3: Data S2) to identify genes for which
transposon insertion abundance [40] differed significantly
between the BCG Danish and BCG Pasteur input trans-
poson libraries. Transposon insertions in seven genes were
found to be significantly less abundant in BCG Danish
than in BCG Pasteur when grown in vitro. These included
three PDIM synthesis genes, ppsA, ppsD and ppsE, which
were predicted to be growth advantaged in BCG Pasteur.
In contrast, insertions in 240 genes were significantly less
abundant in BCG Pasteur than in BCG Danish. These in-
cluded drrA, drrB and drrC, which were predicted to be
essential in BCG Pasteur but not Danish and the
two-component regulator, phoPR; the phoR gene of BCG
Danish is non-functional due to a frameshift at residue 91
(Additional file 1: Table S2) [26]. Many reductive sulfate
assimilation genes, such as sulP, cysA1, cysT, cysN, cysH
[24, 41] and sirA, were also predicted to be essential in
BCG Pasteur but not Danish.
The infection model
Aliquots of the frozen BCG Pasteur or BCG Danish in-
put libraries containing 3.1 × 108 cfu and 1.25 × 108 cfu
(Fig. 1) respectively, were injected into the left and the
right prescapular lymph nodes of three calves. After 3
weeks, the nodes were excised and the BCG recovered.
The nodes contained between 2.6 × 104 and 1.7 × 106 cfu,
equating to libraries predicted to contain between 6.8 ×
103 to 4.7 × 104 unique inserts (Fig. 1). These rates of
recovery are similar to those observed previously in cat-
tle [35] and in other infection models [10]. Differences
in the percentage of bacilli recovered, and in the pre-
dicted numbers of unique inserts, in the two libraries
were not significantly different, although recoveries for
BCG Danish were generally lower than for BCG Pasteur.
Neither was there a significant correlation in the number
of BCG recovered from the left and right lymph nodes
of individual animals, indicating the absence of systemic
differences in BCG survival between individual calves.
Nor was there a significant difference between the num-
ber of BCG recovered from the left, and from the right
nodes, indicating and that there was no bias for survival
for either of the nodes.
In vivo gene fitness prediction in Pasteur and Danish
libraries
When the BCG Danish and BCG Pasteur transposon
libraries recovered from the lymph nodes of the cattle
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were compared to the inoculating input library, 274 and
100 genes respectively were determined to be attenuated
in vivo (Additional file 2: Data S1). Notable functional
gene groups included:
Mycobactin synthesis
Transposon insertion in many of the mycobactin synthe-
sis genes mbtABCDEFG (BCG Danish) and mbtBDEF
(BCG Pasteur) were strongly attenuating during passage
in the cattle (p = 5 × 10− 16 and 0.0002 respectively,
Fig. 2), indicating that iron uptake via mycobactin is
important for persistence of BCG in the bovine lymph
node.
Phthicerol dimycocerosates (PDIM) synthesis
Transposon inserts in genes involved in PDIM synthesis
(p = 7 × 10− 13), notably fadD26, fadD28, ppsABCDE,
mas and papA5 were predicted to be attenuating in
BCG Pasteur in vivo (Fig. 2); but were not significantly
attenuating in BCG Danish. In the in vitro selected input
library, PDIM synthesis genes were predicted to have a
growth advantage ie they were over-represented in the
BCG Pasteur input library but not in the Danish input
library. These results indicated that the PDIM of the
BCG Pasteur and BCG Danish libraries differed in their
physiological functions both in vitro and in vivo. To
investigate this phenomenon further, we compared
PDIM extracted from BCG Pasteur and BCG Danish
and observed that BCG Danish contained lower
amounts of PDIM than BCG Pasteur (Additional file 1:
Figure S2). This is likely due to a frameshift in PDIM
synthesis gene, ppsC identified by Whole Genome
Sequencing of the BCG isolates used to construct the
library (Additional file 1: Table S2). This frameshift is
liable to cause a change in the structure of the PDIM of
BCG Danish. PDIMs are well established as important
virulence factors in M. bovis and M. tuberculosis in mice
[42] and guinea pigs [43]. These data demonstrate that
PDIM also play a role in persistence of BCG in cattle;
albeit one that is dependent on a complete synthesis of
the lipid.
Reductive sulfate assimilation
Transposon inserts in genes involved in the reductive
sulphur assimilation pathway from SO4 to cysteine, eg
cysA1, cysW, subI, cysN, sirA, cysK1 were predicted to be
attenuating in BCG Danish (p = 2.5 × 10− 5, Figs. 2 and 3).
In environments where reduced sulfur metabolites are
unavailable this sulfate assimilation is important for the
generation of sulphated metabolites such as amino acids,
cofactors, etc. Of particular relevance are molecules such
as mycothiol that regulate and counter oxidative stress
[44]. In BCG Pasteur many of these genes were deter-
mined to be essential in vitro and so were absent from the
input library.
Sugar transport
Transposon insertions in the genes associated with BCG’s
two ABC sugar transport systems, the trehalose recycling
system sugABC, lpqY, and BCG_2057c to BCG_2060c
(Rv2038c to Rv2041c) were attenuating in vivo in both
BCG Danish and in BCG Pasteur (Fig. 2). Insertions in the
four genes that precede sugABC, BCG_1291c to
BCG_1294 (equivalent to Rv1231c-Rv1234), were also
Fig. 1 Numbers of BCG and the number of unique insert in the inoculating and recovered libraries. The predicted number of unique inserts were
determined by plotting and extrapolating accumulation curves (Additional file 1: Figure S1a and b). Error bars represent standard errors for colony
counts and root mean square errors for unique insert predictions
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associated with loss of fitness, suggesting that these genes
may also be involved in trehalose recycling.
Cholesterol metabolism
Transposon insertions in many genes involved in choles-
terol catabolism, had significantly reduced fitness in the
bovine lymph nodes for BCG Danish (Fig. 2, p = 0.016).
A similar but non-significant effect was observed for
BCG Pasteur. These included parts of the igr region [45]
involved in the degradation of cholesterol’s side chains,
and members of the kstR2 regulon [46] (p = 0.01 and
0.09). Interestingly, no fitness defect was detected for
Fig. 3 The assimilatory sulfate reduction pathway of BCG Danish. Gene names are coloured to indicate there log2 fold change during the BCG
Danish in vivo passage in cattle. APS - Adenylyl-sulfate
Fig. 2 Bean plot of fold changes during in vivo passage in cattle for selected gene groups. White dashes represent fold changes for individual
genes, black bars the median value of the group. The grey regions is a density plot of the data’s distribution. Values are normalised to the
median value of the appropriate ‘All gene’ group. Essential cholesterol genes were those described by Griffin et al, 2011 [64] less the mce4
operon. The plots were created with BoxPlotR [80], p values are from hypergeometric tests, * < 0.05, ** < 0.01, *** < 0.001
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the genes of the cholesterol transporting mce4 operon
that was required for virulence of M. tuberculosis in
mouse models [31, 47]. These data demonstrate that an
ability to catabolise cholesterol remains important for
BCG to survive in cattle, but that a cholesterol transport
system other than mce4 may be operating.
Identification of novel genes involved in BCG persistence
Although our data highlights the in vivo requirement for
many previous recognised virulence factors, the majority
of the genes identified as being involve in persistence of
BCG in the bovine lymph node have not previously been
ascribed fitness or virulence phenotypes. To confirm
that these putative novel virulence factors are indeed
involved in BCG persistence in vivo, we selected three
genes that have not previously been recognised as being
important for survival in animals, but that were
predicted by these studies to be attenuating during in
vivo passage. The genes selected were BCG_2988c
(Rv2967c), BCG_1063 (Rv1006) and BCG_3780
(Rv3720). These encode respectively, pyruvate carboxyl-
ase, a hypothetical protein, and a possible cyclopropane-
fatty-acyl-phospholipid synthase. Knockouts of these three
genes were generated in BCG Danish using specialised
transduction and confirmed by PCR and Sanger sequen-
cing. As a control, a double knockout of BCG_3679c
(Rv3615c, espC) and BCG_3680c (Rv3616, espA), genes
that were not predicted by transposon analysis to contrib-
ute to in vivo fitness, was also generated.
We first determined whether the loss of the genes had
a non-specific growth defect by tested their in vitro fit-
ness, in a competition assay. When co-cultured with
wild type BCG in 7H9 media none of the mutants
showed a loss of fitness when compared to WT (Fig. 4a).
We next sought to determine whether the putative
BCG persistence genes influenced their ability to survive
the innate immune responses present in bovine macro-
phages by infecting peripheral blood mononuclear cell
(PBMC) derived bovine macrophages with a mixture of
WT BCG and the knockout (KO) mutants. None of the
KO mutants were attenuated, when compared to the
wild type in macrophages (Fig. 4b).
Finally, we sought to confirm the in vivo fitness
phenotypes of the genes that were predicted by the
transposon library data. KO mutants were mixed with
wild type BCG Danish at approximately equal ratios and
inoculated into the prescapular lymph nodes of 5 cattle
using the same protocol as was used for the transposon
library inoculation. After 3 weeks the mix of mutants
and WT were recovered from the lymph nodes and enu-
merated on selective media. All of the knockouts showed
significant attenuation except for the BCG_3615c/3616
control (Fig. 4c).
Discussion
The ability of the BCG vaccine strain to persist in bovine
lymph nodes involves both previously recognised
virulence genes, as well as a large number of genes
whose involvement in mycobacterial virulence has not
so far been suspected. An examination of the gene
groups identified as involved in this ability to persist in
vivo reveals an interaction with the host that is far from
passive, but rather is characterised by specific require-
ments that share commonality with the interactions that
are known to occur during virulent mycobacterial infec-
tion. Notable amongst these fitness associated genes
were groups associated with mycobactin synthesis, sulfur
assimilation, PDIM synthesis, sugar transport and chol-
esterol degradation.
Transposon insertions in the mycobactin gene cluster
and associated genes were highly attenuating in both
BCG Pasteur and BCG Danish. Mycobactin is a sidero-
phore used to acquire iron in low iron environments
[48–50]. These genes are known virulence factors in M.
tuberculosis: ΔmtbE mutants are severely attenuated in
guinea pigs and induce lower levels of pathology [50],
while ΔmtbB mutants are attenuated for replication in
THP-1 macrophages [48].
Genes of the reductive sulfur assimilation pathway
were also required for BCG’s persistence in vivo with in-
activation of many of the pathway’s genes being attenu-
ating in BCG Danish. The generation of sulfated
metabolites, in particular cysteine, has a crucial role in
the intracellular survival of M. tuberculosis, both for
growth and to protect against redox disruption and
oxidative stress via the production of mycothiol [51].
There are conflicting reports of the importance of this
reductive sulfur assimilation pathway in mycobacteria.
Knockouts of cysH have been shown to attenuate M.
tuberculosis in immunocompetent mice [52], and genes
of the pathway are upregulated in intracellular M. tuber-
culosis [53]. However, in BCG, cysA and subI mutants
are not impaired for survival in mice [41, 54], suggesting
that the bacillus is able to acquire reduced sulfur nutri-
ents such a methionine from the murine host. In con-
trast, the requirement for a sulfate assimilation pathway
in these cattle experiments implied that such reduced S
compounds [41, 44, 54] were not present in sufficient
quantities to compensate for the loss of gene function
and so may leave mutants lacking the sulfate reducing
pathway susceptible to oxidative stress [44]. The loss of
fitness observed for knockouts in several other genes
involved in resistance to oxidative stress, such as katG,
caeA and sodC, all of which were severely attenuating in
our model further suggests that the BCG bacilli experi-
ence oxidative stress in the cattle lymph nodes.
Mycolipids were clearly involved in the ability of BCG
Pasteur to persist in the host with many of the genes
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required for PDIM and PGL production such as the
ppsABCDE gene cluster, tesA, mas, papA5, fadD26 and
fadD28, all predicted to be attenuating in cattle. This at-
tenuation was highlighted as many of these mutants
were predicted to be growth advantaged in the input li-
brary, a phenomena observed previously in PDIM/PGL
knockout mutants in M. tuberculosis and BCG [55]. A
loss of PDIM is well documented as leading to a loss of
virulence in M. tuberculosis and has been demonstrated
to attenuate BCG Pasteur in immunocompromised
SCID mice, and too lead to a loss of BCG’s protective
efficacy in immunocompetent BALB/c mice [56]. An
equivalent PDIM phenotype was not seen in BCG
Danish mutants: they were neither attenuated in cattle
lymph nodes, nor did they have a growth advantage in
the in vitro grown input library. This is likely attributed
to a spontaneously acquired frameshift mutation identi-
fied in the ppsC gene of the BCG Danish used in these
experiments. Although this mutation did not abolish
PDIM, it did reduce the relative amount. The frameshift
is also likely to lead to an altered PDIM structure as it is
predicted to abolish the ketoreductase domain of PpsC.
A frameshift mutation in a similar location in the ppsC
of M. marinum also reduced the amount of PDIM rather
than abolishing production, but did lead to an increase
in triacylglycerides (TAGs), the loss of a lipid species (as
determined by thin layer chromatography), and to an in-
crease in cell wall permeability [57]. Mutations leading
to loss of PDIM in mycobacteria occur regular during in
vitro culture [55] and have occurred independently dur-
ing the development of several BCG strains, including
BCG Japan, Moreau and Glaxo [27, 56], underlining the
advantage of performing our analysis in two different
BCG strains.
Sugar transport, or at least recycling, was also clearly
involved in persistence of BCG in the bovine host. BCG
has two ABC sugar transporters. The sugABC, lpqY sys-
tem recycles trehalose that is released by the antigen85
complex during mycolic acid synthesis. This function is
known to be important for virulence and was previously
identified as involved in virulence in a M. tuberculosis
transposon library screen using an intravenous mouse
model of infection [31]. The predicted attenuation of
mutants in the preceding genes suggests that these genes
also have a role in trehalose recycling. Very little is
known about BCG’s other ABC sugar transport system,
BCG_2057c to BCG_2060c, with no previous reports of
a virulence phenotype.
The ability to degrade cholesterol is a well-known
virulence determinant for M. tuberculosis [58–60]. Sterol
a b
c
Fig. 4 Competitive survival of selected mutants in vitro, ex vivo and in cattle. Competitive survival of selected mutants in (a) media, (b) bovine
macrophages and during (c) in vivo survival in cattle. Approximately equal amounts of WT BCG Danish and selected knockouts were mixed and
grown in media, infected into PBMC derived bovine macrophages, and inoculated into cattle lymph nodes. Inoculants and recovered BCG were
enumerated on selective media. Cattle lymph nodes were resected after 3 weeks emulsified and BCG enumerated on selective media.
Significance of the in vivo survival between of the three knockouts and the WT and control were all p < 0.001 using Tukey’s test. Error bars
represent standard errors
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catabolism is thought to provide carbon for both growth
and respiration [61], as well as providing a mechanism
to manipulate the host cell’s immune response [62]. In
BCG Danish, transposon insertions in many of the genes
involved in cholesterol metabolism were found to be at-
tenuating, in particular genes of the igr operon [63],
which degrade the cholesterol side chain [45], and hsaC
together with many of the genes of the kstR2 regulon
[46]. Many of these regions were also identified by
Griffin et al [64] in a genome-scale transposon library
based assessment of genes required for in vitro growth
on cholesterol, but with the notable exception of the
mce4 region that encodes a cholesterol transporter. The
absence of a phenotype for tranposon insertions in the
mce4 operon, yet clear attenuation when genes encoding
enzymes of the cholesterol degradation pathways are
inactivated, implies the existence of an alternative
mechanism of acquiring cholesterol that is active in
these cattle experiments. This conclusion is consistent with
data that shows that M. tuberculosis Δmce4A can continue
to grow on cholesterol as a sole carbon source [65, 66], but
contrasts with data from mice where a Δmce4A mutant
has been shown to be attenuated [31, 66].
Although many of the genes identified as being
required for persistence of BCG in the bovine lymph
node had previously been identified as virulence genes
in a variety of other models, many others had not previ-
ously been associated with virulence. To investigate and
validate the transposon-predicted in vitro, ex vivo and in
vivo phenotype of three of these genes we carried out a
competition experiments with KO BCG strains. All three
knockout strains behaved similarly to wild type BCG
during in vitro culture, and during survival in bovine
macrophage, but were attenuated during passage in cat-
tle lymph nodes. The role of these genes in virulence has
not previously been suspected so we will now assess
their possible roles.
Pyruvate carboxylase’s primary function is the fixation
of CO2 to generate oxaloacetate from pyruvate and so
replenish the TCA cycle [67]. Our data show that al-
though this function is not required for growth in cul-
tured cells, a result consistent with lack of a phenotype
reported for M. tuberculosis Δpca in human THP-1 cells
[67], the genes is nevertheless required for persistence of
BCG in cattle lymph nodes.
BCG_1063 is a hypothetical protein. Very little is
known of its function. It is pseudogenised in M. leprae,
but its phenotype has not been further investigated.
BCG_3780 is a possible cyclopropane-fatty-acyl
-phospholipid synthase, a family of mycobacterial en-
zymes that add methyl groups to unsaturated fatty acids
to generate the cyclopropanate rings found in lipids such
as mycolic acids and phospholipids [68]. BCG contains
several orthologs of BCG_3780, some of which can
impact virulence by modifying the inflammatory
response [69]. Individual gene KOs are associated with
both attenuation [70] and hypervirulence [71]. The
closest BCG_3780 ortholog in the BCG Pasteur genome
is ufaA1 [68], a gene that in M. tuberculosis methyl-
ates oleic acid to produce the immunomodulatory
molecule, tuberculostearic acid [72]. It is possible that
ΔBCG_3780c fitness phenotype is mediate via an as
yet unknown fatty acid in a similar manner to its
orthologs; or that it complements ufaA1, whose
expression is downregulated in BCG Danish and BCG
Pasteur due to a mutation in the start codon of its
regulator sigK [73].
These data demonstrate that the mode of attenuation
of these mutants was not simply due to generalised
growth defects, or to an ability to survive the innate
immune response of cultured macrophages, but rather is
related to the multi-faceted environment found in whole
animal lymph nodes.
Conclusions
BCG is the most widely used vaccine in the world and
yet the mechanisms by which it is able to survive in the
host to provoke a long-lasting immune response are
virtually unknown. In this study we use transposon
mutagenesis to, for the first time, dissect this important
capacity. We demonstrate that survival of BCG in the
bovine host requires a large number of genes, some of
which have been previously identified as being involved
in virulence in pathogenic mycobacteria, while many
more have no previously described virulence role. The
genes identified indicate that the survival of BCG in the
host involves specific interactions between the bacilli
and the host’s immune system that share similarities
with the pathogenic processes observed for virulent
mycobacteria. We confirm that three of these novel
virulence genes are indeed required for persistence in
the host, but in ways that were not demonstrable by
standard in vitro and ex vivo assays of virulence. Further
investigation of the function of these genes may uncover
novel aspects of pathogenesis that could be targeted by
novel therapies or subunit vaccines; or may be used to
engineer a new generation of safer and more effective
live mycobacterial vaccines.
Methods
BCG culture
Mycobacterium bovis BCG Pasteur 1173P2 and M. bovis
BCG Danish 1331 (Staten’s Serum Institut, batch
111013B) were grown at 37 °C on 7H11 with 10%
OADC, or in 7H9 with 10% OADC and 0.05%
Tween®80. For BCG Danish, growth on solid media was
stimulated by ensuring a high titer inoculum was present
in the Petri dish (this was not necessary for BCG
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Pasteur). When selection was required antibiotics were
used at 25–50 μgml− 1 for kanamycin, 50 μgml− 1 for
hygromycin, 25 μgml− 1 for zeocin and 50 μgml− 1 for
apramycin. Both strains were Whole Genome Sequenced
at over 30 fold coverage and aligned to the BCG Pasteur
1173P3 genome (NC_008769) and SNPS and Indels deter-
mined (MicrobesNG, http://www.microbesng.uk, UK).
Transposon library construction
Transposon libraries were generated according to Long
et al [74]. Briefly, 100 ml of late log M. bovis BCG cul-
ture was washed twice in MP buffer (50 mM Tris-HCl,
pH 7.5, 150 mM NaCl, 10 mM MgSO4, 2 mM CaCl2) at
37 °C, and then incubated with more than 1 × 1011 pfu
of MycoMarT7 phage for either 4 h, or overnight. The
suspension was recovered by centrifugation and plated
on ten 15 cm plates, and the library enumerated by serial
dilution. After 3–4 weeks the library was scraped from
the plates and aliquots frozen at − 80 °C.
Inoculation and recovery of tranposon libraries from cattle
A frozen aliquot of each transposon library was
re-suspended overnight in 7H9 to allow it to disperse.
Male, Holstein-Friesian calves of 4–6 months of age
were obtained from UK farms located in bovine TB-free
areas and were housed in appropriate BSL2 animal ac-
commodation. Aliquots of each of the input libraries
containing approximately 1 × 108 cfu (OD600 ~ 1.0) were
inoculated into both the left and right, prescapular
lymph nodes of three calves, as described by
Villarreal-Ramos et al [35]. After 3 weeks, the calves
were euthanised and the lymph nodes were excised,
surface sterilised and macerated in PBS. BCG were
enumerated and the whole library (the output library)
was plated on selective media in 15 cm Petri dishes.
Correlation between BCG numbers recovered from left
and right lymph nodes were assessed using Pearson’s
correlation coefficient and the significance of differences
in the number of BCG recovered from individual cattle,
and between left and right lymph node were assessed by
2-way ANOVA without replication. Differences between
the percentage recovery for BCG Danish and BCG
Pasteur input were assessed with a t-test.
Preparation and sequencing of recovered libraries
DNA from inoculating and selected transposon libraries
was isolated using the enzymatic lysis protocol of Belise
et al [75] and transposon junctions amplified using a
modified version of the protocol described by Long et al
[74]. Briefly, a 5 μg aliquot of the DNA was sheared in
Covaris® Sono 7 machine with settings: Incident Power
105, Duty Factor 5%, 200 cycles/burst for 80 s. The ends
were repaired, blunt ended, and ‘A’ overhangs added,
using the NEB End-It™ and NEB A-tailing kits
(Epicentre, UK). Equimolar amounts of linkers, Adap1
and Adap2 (Additional file 1: Table S1) were annealed
by heating to 95 °C for 5 min in 50 μM MgCl2 and cool-
ing slowly to room temperature. The annealed linkers
were ligated to the ‘A’ tailed ends at × 100molar excess
with T4 DNA ligase for 2 h at room temperature. After
each step the extract was cleaned using QIAquick® PCR
cleanup kits, with extra washes after the ligation step.
Transposon junctions were amplified using primers, IS6
and MarA to MarE (Additional file 1: Table S1), cycle
condition were 95 °C for 10 s, 58 °C for 10 s, 72 °C for 30 s.
The primers were designed to have a P5-index that
identifies the sample and a random P7-index to allow
PCR-generated artefacts to be identified and removed
from the data. Real-time PCRs using EvaGreen® were used
to determine the minimum number of cycles required to
amplify the transposon junctions, and so minimise PCR
amplification artefacts. PCR products between 400 and
600 bp were size selected on agarose gels, and extracted
with QIAquick® Gel extraction kits. The PCR fragment
sizes were determined and quantified using a Bioanalyser
2100 and a mix of equimolar quantities of each prepar-
ation sequenced using a HiSeq®2500 with a single
sequence read and double index reads.
Analysis of transposon-site data
Sequence data were demultiplexed using the P5-index
reads, and quality controlled and aligned as described by
Mendum et al [76]. An additional step removed artefac-
tual amplicons generated by PCR amplification, which
were identified as those reads having both identical
P7-index reads and the same genomic insertion site.
Reads were aligned to the M. bovis BCG Pasteur 1173P2
genome (NC_008769) using Bowtie [77] and the trans-
poson counts determined. Gene essentiality in the input
libraries was predicted using TRANSIT’s [39] HMM
method but excluding TA sites with a non-permissive
motif as identified previously in M. tuberculosis [38].
The significance of differences in insertion rates be-
tween sites with permissive and non-permissive motifs
was assessed using a chi-squared test. Direct compari-
son between the Pasteur and Danish input libraries,
and between the input libraries and the output librar-
ies that were recovered from the cattle, were carried
out using TRANSIT’s Resampling method [40] with
TRR normalisations, and the non-permissive sites
removed. Genes were deemed attenuated in cattle if
they had a corrected p value (q-value) < 0.05 in at
least 2/3 of the 6 lymph nodes (Danish/Pasteur
respectively) and had an average fold change across
all the lymph nodes of more than 10 fold (log2 = 3.32).
The significance of gene group enrichments were deter-
mined with hypergeometric tests.
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Selection and construction of BCG Danish knockout mutants
Three genes that had not previously been ascribed viru-
lence roles were chosen to test the tranposon-library
based predictions. The genes were chosen to fulfil two
roles: to confirm the tranposon predictions and to
positively identify new virulence factors. We picked
pyruvate carboxylase with a well-established function; a
cyclopropane-fatty-acyl-phospholipid synthase, with a
poorly annotated function and a hypothetical gene with
no annotated function. These were ranked 131st, 23rd
and 89th most attenuated in vivo in BCG Danish (by
fold change) out of 274 attenuating genes. To produce
the knockout strains we constructed zeomycin and
kanamycin resistant derivatives of pYUB854 (Hyg) (Bar-
darov et al, 2002), pANE001 (Zeo) and pANE002 (Kan).
An inverse PCR using primers pYUB_inv_F and pYU-
B_inv_R was used to amplify the plasmid backbone of
pYUB854 less the hygromycin cassette, and to add Nde1
and Mfe1 restriction ends. Zeomycin and kanamycin
cassettes were amplified from plasmids pNCMTB and
pMV306 [78] respectively, using primers, Zeo_casset_F/
R and Kan_casset_F/R containing Nde1 and Mfe1 re-
striction sites at their 3′ ends. The antibiotic cassettes
were then cloned into the pYUB854 backbone to give
pANE001 and pANE002, and the constructs confirmed
by Sanger sequencing. Genomic sequence upstream (LF)
and downstream (RF) of the genes to be knocked out
were PCR amplified using primers BCG2988_RF_R,
BCG2988RF_L, etc. and cloned either side of the anti-
biotic cassettes of the cosmids pYUB854, pANE001,
pANE002 and the apramycin resistant cosmid p0004S (a
gift from W. R. Jacobs Jr). Transducing phage were con-
structed and transduced into BCG using the
pHAE159 mycobacteriophage-based method of
specialized transduction (Bardarov et al, 2002). The
knockouts were confirmed by PCR using primers
outside of the upstream and downstream flanking
regions both alone and in combination with antibiotic
cassette specific primers, such that PCR products
would only be obtained if the antibiotic cassettes were
in the predicted configuration. Primer sequences are
listed in Additional file 1: Table S1.
In vitro competition assays
A mix containing approximately equal amounts of the
four mutants and WT BCG Danish were inoculated
into broth and cultured for 14 days. At selected time
points the numbers of each mutant were determined
by serially diluting onto selective media. Numbers of
wild type BCG were estimated by subtracting the
antibiotic resistant colony numbers from counts from
plates without antibiotics. The assays were repeated
three times.
Bovine macrophage preparations and infections
Heparin-anticoagulated blood was collected from
adult cows and the peripheral blood mononuclear
cells (PBMCs) isolated using Ficoll-Histopaque density
gradient centrifugation from which the monocytes
were isolated using CD14 MicroBeads (Miltenyi Bio-
tec). The monocytes were differentiated into macro-
phages in 24 well plates containing complete RPMI
supplemented with 1% sodium pyruvate, 1% penicil-
lin/streptomycin and 20 ng ml− 1 of macrophage
colony-stimulating factor (Miltenyi Biotec). Fresh
medium was added at day 3 before cells were infected
on day 6, at an MOI of 1, with a mixed BCG culture
containing approximately equal amounts of wild-type
and of each of the individual knockouts. After 4 h,
the infected cells were washed three times with PBS.
The intracellular bacilli were harvested at different
time points by lysing the cells with 0.1% Triton™
X-100. The mixed culture used for infection, and har-
vested intracellular bacilli were enumerated as de-
scribed for the in vitro competition assay. The assays
were repeated three times.
Inoculation and recovery of selected knockouts from cattle
To test the in vivo phenotype of selected BCG knock-
outs both the left and right pre-scapular lymph nodes
of 5 cattle were inoculated with a mix of ~ 1 × 108 cfu
containing approximately equal numbers of each mu-
tant and the wild type in the same manner as described
for the transposon libraries. After 3 weeks the cattle
were euthanized and the left and right lymph nodes
from each cow excised and pooled and macerated. BCG
were enumerated as described for the macrophages.
Significance between the percentage abundance of each
mutant in the recovered BCG were determined by
One-way ANOVA and Tukey’s post-hoc test.
Lipid analysis
Lipids were extracted from mycobacterial cells in three
fractions as described by Dobson et al [79], with a few
modifications. Briefly, free lipids from dried pellets were
extracted with two consecutive extractions of 4 ml of
petroleum ether (60–80 °C), and dried. Then, 2 ml of
CH3OH: 0.3% NaCl (10:1, v/v) were added to the
remaining pellets. To extract apolar lipids, two sequen-
tial extractions with 2 ml of petroleum ether (60–80 °C)
were carried out, and upper organic layers were dried.
For polar lipid extraction, 2.3 ml of CHCl3/CH3OH/0.3%
NaCl (9:10:3, v/v/v) was added to the previous lower
layer. The resulting supernatant was collected in another
tube along with the supernatants obtained after washing
the remaining pellets twice with CHCl3/CH3OH/0.3%
NaCl (5:10:4, v/v/v). Equal volumes of CHCl3 and 0.3%
NaCl were then added, and the lower phase was
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removed and dried. All lipids were resuspended in
200 μl of CHCl3/CH3OH (2:1, v/v). Apolar lipids were
separated by 2D TLC using petroleum ether/ethyl acet-
ate 98:2, followed by petroleum ether/acetone 98:2 and
visualised by charring after staining with 5% molybdo-
phosphoric acid.
Additional files
Additional file 1: Supplementary Tables and Figures. Genomic
differences between the strains, accumulation plots from which library sizes
were estimated, primer sequences and lipid analysis. (DOCX 1109 kb)
Additional file 2: The predicted essentiality and in vivo fitness of BCG
genes. Output from the comparisons between the input and output
libraries, describing the relative fitness of each gene during passage
through the cattle. (XLSX 2251 kb)
Additional file 3: Differences in in vitro fitness between BCG Danish
and BCG Pasteur input libraries. Output from the genomic comparisons
of the two input libraries describing relative in vitro fitness between BCG
Danish and BCG Pasteur. (XLSX 241 kb)
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